Thrombosis among 1537 patients with JAK2 V617F ‐mutated myeloproliferative neoplasms: Risk factors and development of a predictive model-Reference-Cited by-同舟云学术

Thrombosis among 1537 patients with JAK2 V617F ‐mutated myeloproliferative neoplasms: Risk factors and development of a predictive model

Published:2020-01-28 Issue:6 Volume:9 Page:2096-2105
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Zhang Yuhui¹,Zhou Yuan²,Wang Yingshao¹²,Teng Guangshuai¹,Li Dapeng²,Wang Yan¹,Du Chenxiao¹,Chen Yafang¹,Zhang Huiqin¹,Li Yanqi¹,Fu Lixia¹,Chen Kangyin³,Bai Jie¹^ORCID

Affiliation:

1. Department of Hematology The Second Hospital of Tianjin Medical University Tianjin China

2. State Key Laboratory of Experimental Hematology Institute of Hematology & Blood Diseases Hospital National Clinical Research Center for Blood Diseases Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China

3. Tianjin Key Laboratory of Ionic‐Molecular Function of Cardiovascular Disease Department of Cardiology Tianjin Institute of Cardiology Second Hospital of Tianjin Medical University Tianjin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2886

Reference27 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Acute Transformation in Nonleukemic Chronic Myeloproliferative Disorders: Actuarial Probability and Main Characteristics in a Series of 218 Patients

3. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases